1. Loscher, W. 1985. Valproic acid. Pages 507–537, in Frey, H.,
Janz, D. (eds), Handbook of Experimental Pharmacology.
Springer-Verlag, Berlin.
2. Calabrese, J. R., Bowden, C., and Woyshville, M. J. 1995. 21.
Lithium and the anticonvulsants in the treatment of bipolar disorder. Pages 1099–1111, in Bloom E., and Kupfer D. (eds),
Phychopharmacology: The Fourth Generation of Progress.
Raven, New York, NY. 22.
3. Loscher, W. 1993. Effects of the antiepileptic drug valproate on
metabolism and function of inhibitory and excitatory amino
acids in the brain. Neurochem. Res. 18:485–502.
4. Johannessen, C. U. 2000. Mechanisms of action of valproate: A
commentatory. Neurochem. Int. 37:103–110. 23.
5. Bolanos, J. P. and Medina, J. M. 1997. Effect of valproate on
the metabolism of the central nervous system. Life Sci.
60:1933–1942. 24.
6. Williams, R. S., Cheng, L., Mudge, A. W., and Harwood, A. J.
2002. A common mechanism of action for three mood-stabilizing
drugs. Nature 417:292–295.
7. Friel, P. 1990. Valproyl CoA: An active metabolite of val- 25.
proate? Med. Hypotheses 31:31–32.
8. Siafaka-Kapadai, A., Patiris, M., Bowden, C., and Javors, M.,
1998. Incorporation of [3H]valproic acid into lipids in GT1–7 26.
neurons. Biochem. Pharmacol. 56:207–212.
9. Shimizu, T. and Wolfe, L. S. 1990. Arachidonic acid cascade
and signal transduction. J. Neurochem. 55:1–15. 27.
10. Chang, M. C., Grange, E., Rabin, O., Bell, J. M., Allen, D. D., and
Rapoport, S. I., 1996. Lithium decreases turnover of arachidonate
in several brain phospholipids. Neurosci. Lett. 220:171–174.
11. Chang, M. C., Contreras, M. A., Rosenberger, T. A., Rintala, 28.
J. J., Bell, J. M., and Rapoport, S. I., 2001. Chronic valproate
treatment decreases the in vivo turnover of arachidonic acid in
brain phospholipids: A possible common effect of mood stabi- 29.
lizers. J. Neurochem. 77:796–803.
12. Rintala, J., Seemann, R., Chandrasekaran, K., Rosenberger, 30.
T. A., Chang, J., Contreras, M. A., Rapoport, S. T., and Chang,
M. C. 1999. 85 kDa cytosolic phospholipase A2 is a target for
chronic lithium in rat brain. Neuroreport 10:3887–3890. 31.
13. Silva, M. F., Ruiter, J. P., IJIst, L., Jakobs, C., Duran, M., de
Almeida, I. T., and Wanders, R. J. 2001. Differential effect of 32.
valproate and its Delta2- and Delta4-unsaturated metabolites, on
the beta-oxidation rate of long-chain and medium-chain fatty 33.
acids. Chem. Biol. Interact. 137:203–212.
14. Silva, M. F., Ruiter, J. P., IJIst, L., Allers, P., ten Brink, H. J.,
Jakobs, C., Duran, M., Tavares de Almeida, I., and Wanders 34.
R. J. 2001. Synthesis and intramitochondrial levels of valproylcoenzyme A metabolites. Anal. Biochem. 290:60–67.
